Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 2006;173: 1390–1413.
Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report; 2019. Available from: http://www.goldcopd.org.
Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo). 2010;65(6): 599–605.
Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. American Journal of Respiratory and Critical Care Medicine. 2006;173: 79–83.
Vermeeren MAP, Creutzberg EC, Schols AMWJ, Postma DS, Pieters WR, Roldaan AC, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med. 2006;100: 1349–1355.
Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One. 2012;7(8): e43892. doi:
10.1371/journal.pone.0043892.
Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, Griffiths TL, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. 2001;164: 1414–1418.
Olveira G, Olveira C, Gaspar I, Porras N, Martín-Núñez G, Rubio E, et al. Fat-free mass depletion and inflammation in patients with bronchiectasis. Journal of the Academy of Nutrition and Dietetics. 2012;112(12): 1999–2006.
Martínez-García MA, Perpiña-Tordera M, Román-Sánchez P, Soler-Cataluña JJ, Carratalá A, Yago M, et al. The association between bronchiectasis, systemic inflammation, and tumor necrosis factor alpha. Archivos de bronconeumología. 2008;44: 8–14.
Alakhras M, Decker PA, Nadrous HF, Collazo-Clavell M, Ryu JH. Body mass index and mortality in patients with idiopathic pulmonary fibrosis. Chest. 2007;131(5): 1448–1453.
Rahman I, Skwarska E, Henry M, et al. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radical Biology & Medicine. 1999;27(1–2): 60–68.
Snetselaar R, van Moorsel CH, Kazemier KM, van der Vis JJ, Zanen P, van Oosterhout MF, Grutters JC. Telomere length in interstitial lung diseases. Chest. 2015;148(4): 1011–1018.
Al-Majid S, Waters H. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biological Research for Nursing. 2008;10: 7–20.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine. 2002;166(1): 111–117.
Franssen FM, Broekhuizen R, Janssen PP, Wouters E, Schols A. Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest. 2004;125: 2021–2028.
Abbatecola AM, Fumagalli A, Spazzafumo L, Betti V, Misuraca C, Corsonello A, et al. Body composition markers in older persons with COPD. Age Ageing. 2014;43(4): 548–553.
Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine. 2004;350(10): 1005–1012.
Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. The American Journal of Clinical Nutrition. 2005;82(1): 53–59.
Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews. 2012;12: CD000998.